Get the Stockscreener App
79.93
1.54%
1.21
After Hours:
79.93
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Bio Techne Corp stock is traded at $79.93, with a volume of 685.81K.
It is up +1.54% in the last 24 hours and up +8.03% over the past month.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
See More
Previous Close:
$78.72
Open:
$78.5
24h Volume:
685.81K
Relative Volume:
0.73
Market Cap:
$12.68B
Revenue:
$1.16B
Net Income/Loss:
$168.11M
P/E Ratio:
52.59
EPS:
1.52
Net Cash Flow:
$236.10M
1W Performance:
+3.52%
1M Performance:
+8.03%
6M Performance:
+13.55%
1Y Performance:
+17.42%
1-Day Range:
$78.00
$80.02
1-Week Range:
$74.57
$80.12
52-Week Range:
$51.79
$85.57
Bio Techne Corp Stock (TECH) Company Profile
Name
Bio Techne Corp
Sector
Industry
Phone
(612) 379-8854
Address
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Bio Techne Corp Stock (TECH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-22-24 | Downgrade | Citigroup | Buy → Neutral |
| Feb-08-24 | Initiated | Scotiabank | Sector Outperform |
| Feb-02-24 | Downgrade | Stifel | Buy → Hold |
| Dec-07-23 | Initiated | UBS | Buy |
| Aug-28-23 | Initiated | William Blair | Outperform |
| Jan-10-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Dec-12-22 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Sector Perform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Apr-25-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Sep-15-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-08-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Feb-23-21 | Upgrade | Stifel | Hold → Buy |
| Jan-25-21 | Reiterated | The Benchmark Company | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-30-20 | Initiated | Atlantic Equities | Overweight |
| Jul-15-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| May-27-20 | Downgrade | Stifel | Buy → Hold |
| May-14-20 | Initiated | The Benchmark Company | Buy |
| Jan-08-20 | Resumed | Stephens | Overweight |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Neutral |
| Nov-15-19 | Initiated | Stifel | Buy |
| Jul-02-19 | Upgrade | Janney | Neutral → Buy |
| Jan-14-19 | Upgrade | Stephens | Equal-Weight → Overweight |
| Oct-31-18 | Downgrade | Craig Hallum | Buy → Hold |
| Oct-17-18 | Initiated | Goldman | Neutral |
| Jun-15-18 | Initiated | Argus | Buy |
| Jul-13-17 | Initiated | Wells Fargo | Market Perform |
| Feb-09-17 | Initiated | Citigroup | Buy |
| Jan-18-17 | Initiated | Deutsche Bank | Buy |
| Nov-10-16 | Resumed | Leerink Partners | Outperform |
| Jan-21-15 | Reiterated | Robert W. Baird | Outperform |
| Sep-20-13 | Upgrade | Robert W. Baird | Neutral → Outperform |
View All
Bio Techne Corp Stock (TECH) Latest News
BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Purchases 11,371 Shares of Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Dimensional Fund Advisors LP Grows Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
13,526 Shares in Bio-Techne Co. (NASDAQ:TECH) Purchased by Deerfield Management Company L.P. Series C - MarketBeat
LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH - Yahoo Finance
Point72 Europe London LLP Raises Stock Position in Bio-Techne Co. (NASDAQ:TECH) - Defense World
Bio-Techne Stock: Is TECH Underperforming The Healthcare Sector? - Barchart
Berenberg lowers target price on Big Technologies - ShareCast
Big Technologies reports weaker first half after loss of Colombia contract - ShareCast
Mutual of America Capital Management LLC Raises Stock Position in Bio-Techne Co. (NASDAQ:TECH) - Defense World
2seventy Bio stops enrolling patients in blood cancer therapy study - Reuters
Bristol Myers, 2seventy bio halt Abecma trial (NASDAQ:TSVT) - Seeking Alpha
Mutual of America Capital Management LLC Raises Stock Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Analyzing Bio-Techne Corp (TECH) After Recent Trading Activity - Knox Daily
Byrna Technologies CEO sells over $670k in company stock By Investing.com - Investing.com Australia
Marshall Wace LLP Sells 108,334 Shares of Bio-Techne Co. (NASDAQ:TECH) - Defense World
BioAtla out-licenses T cell therapy in $134 million deal - The Pharma Letter
Bio-Techne Co. (NASDAQ:TECH) Shares Sold by Epoch Investment Partners Inc. - Defense World
Results from BioNTech SE ADR (BNTX) show potential - US Post News
(BTMD) Technical Pivots with Risk Controls - Stock Traders Daily
A new trading data show BriaCell Therapeutics Corp (BCTX) is showing positive returns. - SETE News
BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING – Company AnnouncementFT.com - Financial Times
Bio-Techne Co. (NASDAQ:TECH) Shares Acquired by Thrivent Financial for Lutherans - MarketBeat
Financial Analysis: BioNTech SE ADR (BNTX)’s Ratios Unveil Key Insights - The Dwinnex
Bio-Techne Co. (NASDAQ:TECH) Shares Sold by Sei Investments Co. - MarketBeat
YieldBoost TECH To 11.2% Using Options - Nasdaq
Biohaven’s stock surges as treatment slows progress of neurological disorder - MarketWatch
Discovery Capital Management LLC CT Invests $2.47 Million in BioNTech SE (NASDAQ:BNTX) - MarketBeat
Brokers Set Expectations for BriaCell Therapeutics Corp.’s FY2024 Earnings (TSE:BCT) - Defense World
Envestnet Asset Management Inc. Cuts Stock Position in Bio-Techne Co. (NASDAQ:TECH) - Defense World
XTX Topco Ltd Raises Stock Position in Bio-Techne Co. (NASDAQ:TECH) - Defense World
XTX Topco Ltd Has $1.22 Million Stake in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Bio-Techne Corp [TECH] Shares Rise 5.03 % on Thursday - Knox Daily
FY2026 EPS Estimates for Bio-Techne Co. (NASDAQ:TECH) Lowered by Analyst - Defense World
Bio-Techne Co. to Post FY2026 Earnings of $2.11 Per Share, Leerink Partnrs Forecasts (NASDAQ:TECH) - MarketBeat
Bio-Techne Corp (TECH) can make a big difference with a little luck - SETE News
Leerink Partnrs Research Analysts Reduce Earnings Estimates for Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Bio-Techne (NASDAQ:TECH) stock performs better than its underlying earnings growth over last five years - Yahoo Finance
BioNTech Is More Than a Covid-19 Stock. It’s Having a Great September. - Barron's
Bio-Techne Corp (TECH)'s Winning Formula: Financial Metrics and Competitive Strengths - GuruFocus.com
Biotalys Granted Patents for EVOCA in Both Europe and the U.S. - CropLife
Daily Market Movement: BioNTech SE ADR (BNTX) Sees a -7.29 Decrease, Closing at 115.62 - The Dwinnex
Edgestream Partners L.P. Cuts Stake in Bio-Techne Co. (NASDAQ:TECH) - Defense World
Bytes Technology Shares Rise On Profit Jump - MarketWatch
Texas Permanent School Fund Corp Sells 6,500 Shares of Bio-Techne Co. (NASDAQ:TECH) - Defense World
Nanobiotix: upbeat after half-year results - Marketscreener.com
Edgestream Partners L.P. Trims Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
UK's Bytes Technology gains on H1 profit growth - XM
Bytes Technology sees "strong" performance in first half - Marketscreener.com
Bytes Technology hails strong first-half trading - ShareCast
Jefferies upgrades BioNTech SE ADR (BNTX) rating to a Buy - Knox Daily
Biotalys Granted Patents for EVOCA in Both Europe and the United States - Chemical Industry Digest
Bio Techne Corp Stock (TECH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):